Vise Technologies Inc. Makes New $731,000 Investment in Avantor, Inc. $AVTR

Vise Technologies Inc. purchased a new stake in Avantor, Inc. (NYSE:AVTR) during the 2nd quarter, Holdings Channel reports. The firm purchased 73,825 shares of the company’s stock, valued at approximately $731,000.

Other hedge funds also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Avantor by 28.1% during the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after buying an additional 905 shares during the period. Osaic Holdings Inc. increased its position in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock valued at $38,000 after acquiring an additional 1,064 shares during the period. UMB Bank n.a. raised its stake in Avantor by 17.6% during the 4th quarter. UMB Bank n.a. now owns 7,371 shares of the company’s stock valued at $84,000 after acquiring an additional 1,101 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in Avantor by 119.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock valued at $29,000 after acquiring an additional 1,189 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its position in Avantor by 0.6% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 206,386 shares of the company’s stock worth $2,576,000 after acquiring an additional 1,279 shares during the period. Institutional investors own 95.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on AVTR shares. Wells Fargo & Company increased their price target on Avantor from $14.00 to $16.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. UBS Group set a $8.00 price objective on shares of Avantor in a research note on Wednesday, June 24th. Wolfe Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, July 30th. Royal Bank Of Canada increased their target price on shares of Avantor from $9.00 to $14.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Finally, Morgan Stanley raised their target price on shares of Avantor from $10.00 to $14.00 and gave the company an “equal weight” rating in a research note on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $12.00.

Avantor Stock Performance

AVTR opened at $14.45 on Monday. The business has a 50 day moving average price of $11.63 and a two-hundred day moving average price of $9.64. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.78 and a quick ratio of 1.18. The company has a market capitalization of $9.77 billion, a price-to-earnings ratio of -17.20, a price-to-earnings-growth ratio of 10.91 and a beta of 0.89. Avantor, Inc. has a 1-year low of $7.26 and a 1-year high of $15.93.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.02. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%.The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.61 billion. During the same period last year, the firm earned $0.24 EPS. The firm’s revenue for the quarter was up .5% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Research analysts predict that Avantor, Inc. will post 0.81 EPS for the current fiscal year.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.